Skip to main content
Top
Published in: Annals of Surgical Oncology 4/2016

01-04-2016 | Gynecologic Oncology

Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus

Authors: Yulia Lakhman, MD, Seth S. Katz, MD, PhD, Debra A. Goldman, MS, Derya Yakar, MD, PhD, Hebert A. Vargas, MD, Ramon E. Sosa, BA, Maura Miccò, MD, Robert A. Soslow, MD, Hedvig Hricak, MD, PhD, Nadeem R. Abu-Rustum, MD, Evis Sala, MD, PhD

Published in: Annals of Surgical Oncology | Issue 4/2016

Login to get access

Abstract

Purpose

The aim of this study was to assess the diagnostic performance of computed tomography (CT) for initial staging of non-endometrioid carcinomas of the uterine corpus.

Materials and Methods

Waiving informed consent, the Institutional Review Board approved this Health Insurance Portability and Accountability Act (HIPAA)-compliant retrospective study of 193 women with uterine papillary serous carcinomas, clear cell carcinomas, and carcinosarcomas, who underwent surgical staging between May 1998 and December 2011 and had preoperative CT within 6 weeks before surgery. Two radiologists (R1, R2) independently reviewed all CT images. Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and area under the curve were calculated using operative notes and surgical pathology as the reference standard.

Results

The respective sensitivities and specificities achieved by R1/R2 were 0.79/0.64 and 0.87/0.75 for detecting deep myometrial invasion (MI) on CT; 0.56/0.63 and 0.93/0.79 for detecting cervical stromal invasion; 0.52/0.45 and 0.95/0.93 for detecting pelvic nodal metastases; and 0.45/0.30 and 0.98/0.98 for detecting para-aortic nodal metastases. Although CT had suboptimal sensitivity for the detection of omental disease, it had high PPV for omental seeding at surgical exploration (1.00 for R1 and 0.92 for R2). Inter-observer agreement ranged from moderate in the detection of deep MI (κ = 0.42 ± 0.06) to almost perfect in the detection of para-aortic nodal metastases (κ = 0.88 ± 0.08).

Conclusion

In patients with uterine non-endometrioid carcinomas, CT is only moderately accurate for initial staging but may provide clinically valuable information by ‘ruling-in’ isolated para-aortic lymph node metastases and omental dissemination.
Literature
1.
go back to reference Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;66(1):9–29.CrossRef Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;66(1):9–29.CrossRef
2.
go back to reference Doll A, Abal M, Rigau M, et al. Novel molecular profiles of endometrial cancer: new light through old windows. J Steroid Biochem Mol Biol. 2008;108:221–9.CrossRefPubMed Doll A, Abal M, Rigau M, et al. Novel molecular profiles of endometrial cancer: new light through old windows. J Steroid Biochem Mol Biol. 2008;108:221–9.CrossRefPubMed
3.
go back to reference Tejerizo-Garcia A, Jimenez-Lopez JS, Munoz-Gonzalez JL, et al. Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients. Onco Targets Ther. 2013;9:1305–13.PubMed Tejerizo-Garcia A, Jimenez-Lopez JS, Munoz-Gonzalez JL, et al. Overall survival and disease-free survival in endometrial cancer: prognostic factors in 276 patients. Onco Targets Ther. 2013;9:1305–13.PubMed
4.
go back to reference Hendrickson M, Ross J, Eifel PJ, Cox RS, Martinez A, Kempson R. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic factors. Gynecol Oncol. 1982;13:373–92.CrossRefPubMed Hendrickson M, Ross J, Eifel PJ, Cox RS, Martinez A, Kempson R. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic factors. Gynecol Oncol. 1982;13:373–92.CrossRefPubMed
5.
go back to reference Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366:491–505.CrossRefPubMed Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366:491–505.CrossRefPubMed
6.
go back to reference Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.CrossRefPubMed Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.CrossRefPubMed
8.
go back to reference Bansal N, Herzog TJ, Brunner-Brown A, Wethington SL, Cohen CJ, Burke WM, et al. The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies. Gynecol Oncol. 2008;111:208–12.CrossRefPubMed Bansal N, Herzog TJ, Brunner-Brown A, Wethington SL, Cohen CJ, Burke WM, et al. The utility and cost effectiveness of preoperative computed tomography for patients with uterine malignancies. Gynecol Oncol. 2008;111:208–12.CrossRefPubMed
9.
go back to reference Connor JP, Andrews JI, Anderson B, Buller RE. Computed tomography in endometrial carcinoma. Obstet Gynecol. 2000;95:692–6.CrossRefPubMed Connor JP, Andrews JI, Anderson B, Buller RE. Computed tomography in endometrial carcinoma. Obstet Gynecol. 2000;95:692–6.CrossRefPubMed
10.
go back to reference Zerbe MJ, Bristow R, Grumbine FC, Montz FJ. Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer. Gynecol Oncol. 2000;78:67–70.CrossRefPubMed Zerbe MJ, Bristow R, Grumbine FC, Montz FJ. Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer. Gynecol Oncol. 2000;78:67–70.CrossRefPubMed
11.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefPubMed
12.
go back to reference AlHilli MM, Mariani A. The role of para-aortic lymphadenectomy in endometrial cancer. Int J Clin Oncol. 2013;18:193–9.CrossRefPubMed AlHilli MM, Mariani A. The role of para-aortic lymphadenectomy in endometrial cancer. Int J Clin Oncol. 2013;18:193–9.CrossRefPubMed
13.
go back to reference Manfredi R, Mirk P, Maresca G, et al. Local-regional staging of endometrial cancer: role of MR imaging in surgical planning. Radiology. 2004;231:372–8.CrossRefPubMed Manfredi R, Mirk P, Maresca G, et al. Local-regional staging of endometrial cancer: role of MR imaging in surgical planning. Radiology. 2004;231:372–8.CrossRefPubMed
14.
go back to reference Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, et al. Radiological staging in patients with endometrial cancer: a meta-analysis. Radiology. 1999;212:711–8.CrossRefPubMed Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, et al. Radiological staging in patients with endometrial cancer: a meta-analysis. Radiology. 1999;212:711–8.CrossRefPubMed
15.
go back to reference Tsili AC, Tsampoulas C, Dalkalitsis N, Stefanou D, Paraskevaidis E, Efremidis SC. Local staging of endometrial cancer: role of multidetector CT. Eur Radiol. 2008;18:1043–8.CrossRefPubMed Tsili AC, Tsampoulas C, Dalkalitsis N, Stefanou D, Paraskevaidis E, Efremidis SC. Local staging of endometrial cancer: role of multidetector CT. Eur Radiol. 2008;18:1043–8.CrossRefPubMed
16.
go back to reference Balfe DM, Van Dyke J, Lee JK, Weyman PJ, McClennan BL. Computed tomography in malignant endometrial neoplasms. J Comput Assist Tomogr. 1983;7:677–81.CrossRefPubMed Balfe DM, Van Dyke J, Lee JK, Weyman PJ, McClennan BL. Computed tomography in malignant endometrial neoplasms. J Comput Assist Tomogr. 1983;7:677–81.CrossRefPubMed
17.
go back to reference Varpula MJ, Klemi PJ. Staging of uterine endometrial carcinoma with ultra-low field (0.02 T) MRI: a comparative study with CT. J Comput Assist Tomogr. 1993;17:641–7.CrossRefPubMed Varpula MJ, Klemi PJ. Staging of uterine endometrial carcinoma with ultra-low field (0.02 T) MRI: a comparative study with CT. J Comput Assist Tomogr. 1993;17:641–7.CrossRefPubMed
18.
go back to reference La Fianza A, Di Maggio EM, Preda L, Coscia D, Tateo S, Campani R. Clinical usefulness of CT in the treatment of stage I endometrial carcinoma. Radiol Med. 1997;93:567–71.PubMed La Fianza A, Di Maggio EM, Preda L, Coscia D, Tateo S, Campani R. Clinical usefulness of CT in the treatment of stage I endometrial carcinoma. Radiol Med. 1997;93:567–71.PubMed
19.
go back to reference Antonsen SL, Jensen LN, Loft A, et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer: a multicenter prospective comparative study. Gynecol Oncol. 2013;128:300–8.CrossRefPubMed Antonsen SL, Jensen LN, Loft A, et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer: a multicenter prospective comparative study. Gynecol Oncol. 2013;128:300–8.CrossRefPubMed
20.
go back to reference Horowitz NS, Dehdashti F, Herzog TJ, et al. Prospective evaluation of FDG-PET for dectecting pelvic and paraaorticlymph node metastases in uterine corpus cancer. Gynecol Oncol. 2004;95(3):546–51.CrossRefPubMed Horowitz NS, Dehdashti F, Herzog TJ, et al. Prospective evaluation of FDG-PET for dectecting pelvic and paraaorticlymph node metastases in uterine corpus cancer. Gynecol Oncol. 2004;95(3):546–51.CrossRefPubMed
21.
go back to reference Suzuki R, Miyagi E, Takahashi N, et al. Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer. Int J Gynecol Cancer. 2007;17(4):890–6.CrossRefPubMed Suzuki R, Miyagi E, Takahashi N, et al. Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer. Int J Gynecol Cancer. 2007;17(4):890–6.CrossRefPubMed
22.
go back to reference Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982;6:93–108.CrossRefPubMed Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol. 1982;6:93–108.CrossRefPubMed
23.
go back to reference Abeler VM, Vergote IB, Kjorstad KE, Kjorstad KE, Trope CG. Clear cell carcinoma of the endometrium. prognosis and metastatic pattern. Cancer. 1996;78:1740–7.CrossRefPubMed Abeler VM, Vergote IB, Kjorstad KE, Kjorstad KE, Trope CG. Clear cell carcinoma of the endometrium. prognosis and metastatic pattern. Cancer. 1996;78:1740–7.CrossRefPubMed
24.
go back to reference Tempany CM, Zou KH, Silverman SG, et al. Staging of advanced ovarian cancer: comparison of imaging modalities: report from the Radiological Diagnostic Oncologic Group. Radiology. 2000;215:761–7.CrossRefPubMed Tempany CM, Zou KH, Silverman SG, et al. Staging of advanced ovarian cancer: comparison of imaging modalities: report from the Radiological Diagnostic Oncologic Group. Radiology. 2000;215:761–7.CrossRefPubMed
25.
go back to reference Coakley FV, Choi PH, Gougoutas CA, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology. 2002;223:495–9.CrossRefPubMed Coakley FV, Choi PH, Gougoutas CA, et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology. 2002;223:495–9.CrossRefPubMed
26.
go back to reference Low RN, Chen SC, Barone R, et al. Distinguishing benign from malignant bowel obstruction in patients with malignancy: findings at MRI. Radiology. 2003;228:157–65.CrossRefPubMed Low RN, Chen SC, Barone R, et al. Distinguishing benign from malignant bowel obstruction in patients with malignancy: findings at MRI. Radiology. 2003;228:157–65.CrossRefPubMed
Metadata
Title
Diagnostic Performance of Computed Tomography for Preoperative Staging of Patients with Non-endometrioid Carcinomas of the Uterine Corpus
Authors
Yulia Lakhman, MD
Seth S. Katz, MD, PhD
Debra A. Goldman, MS
Derya Yakar, MD, PhD
Hebert A. Vargas, MD
Ramon E. Sosa, BA
Maura Miccò, MD
Robert A. Soslow, MD
Hedvig Hricak, MD, PhD
Nadeem R. Abu-Rustum, MD
Evis Sala, MD, PhD
Publication date
01-04-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 4/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4410-x

Other articles of this Issue 4/2016

Annals of Surgical Oncology 4/2016 Go to the issue